Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma
Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma
Synopsis: Andrew Scharenberg is the Co-founder and CEO of Umoja Biopharma, a company pioneering the future of immunother... Read more
9 Aug 2023
•
32mins
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
Synopsis: Theresa Heah, M.D., is the CEO of Intergalactic Therapeutics. Intergalactic is overcoming the limitations of v... Read more
2 Aug 2023
•
19mins
Similar Podcasts
The Readout Loud
Business Of Biotech
FYI - For Your Innovation
The Long Run with Luke Timmerman
Biotech Bros
a16z Podcast
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
BioCentury This Week
Odd Lots
Masters in Business
Inside the Strategy Room
Cold Call
HBS Managing the Future of Work
Masters of Scale
Infinite Loops
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
Synopsis: Volker Herrmann is the President and CEO of Sonata Therapeutics, a Flagship Pioneering company revolutionizing... Read more
26 Jul 2023
•
34mins
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo
Synopsis: Greg Flesher is the President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company focuse... Read more
19 Jul 2023
•
27mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx
Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx
Synopsis: Adrian Gottschalk is the president and CEO of Foghorn Therapeutics, a clinical-stage biotechnology company pio... Read more
12 Jul 2023
•
31mins
Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT
Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT
Synopsis: Jim Brown is the President and CEO of DURECT Corporation, a biopharmaceutical company committed to transformin... Read more
5 Jul 2023
•
29mins
New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio
New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio
Synopsis: James Peyer, Ph.D., is the Founder and CEO of Cambrian Bio, a clinical-stage drug-development company focused ... Read more
28 Jun 2023
•
29mins
Revolutionizing T-cells for solid tumor cell therapies, Gary Lee, CSO, Lyell Immunopharma
Revolutionizing T-cells for solid tumor cell therapies, Gary Lee, CSO, Lyell Immunopharma
Synopsis: Gary Lee, Ph.D. is the CSO of Lyell Immunopharma, a T-cell reprogramming company dedicated to developing cell ... Read more
21 Jun 2023
•
28mins
Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx
Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx
Synopsis: Liang Schweizer, Ph.D. is the Founder and CEO of HiFiBiO Therapeutics, a clinical-stage global biotech company... Read more
14 Jun 2023
•
30mins
BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx
BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx
Synopsis: Detlev Biniszkiewicz is the Founder and CEO of NextPoint Therapeutics, a company advancing the field of immuno... Read more
7 Jun 2023
•
34mins
